The global Sleep Apnea Devices Market was valued at USD4.35 billion in 2018 and is expected to reach USD 8.81 billion in 2026, growingat a CAGR of 9.2% during the forecast period.
The sleep apnea devicesindustry is primarily driven by an increase in the obese population and growingawareness for better health. Moreover, the availability of large venturecapital funds to develop and offer the most efficient and technologically soundsleep apnea device is further propelling the industry growth. Key industryplayers are increasingly focussing on untapped markets in developing regionssuch as China and India to gain industry stronghold.
Sleep apnea is defined asa human breathing disorder which results in symptoms such as loud snoring andchoking during sleeping. Sleep apnea usually consists of three types whichinclude obstructive sleep apnea, central sleep apnea, and complex sleep apneasyndrome. Fluctuation in breathing, loud snoring, occasional choking orsnorting, lack of sleep and conscious attention, etc. are some of the majorsymptoms of sleep apnea disorder. Sleep apnea usually occurs due to obesephysical structure, the large circumference of the neck, smoking and drinkinghabits, among others. Sleep apnea devices are developed in order to trace andtreat this disorder as it is very difficult to detect with normal methods.
North America to dominate the sleep apnea devicesmarket throughout the forecast period
North America region is by far the largestcontributor to the growth of global Sleep apnea devices market whichcontributed more than 37% market share globally. However, Asia Pacific regionis anticipated to showcase the highest growth rate during the forecast periodowing to intensifying investments from global industry players.
Company Profiles and Competitive Intelligence:
The major players operating in the global sleepapnea devices market are Koninklijke Philips (Netherlands), Fisher & PaykelHealthcare (New Zealand), SomnoMed (US), Oventus Medical (Australia),Compumedics (Australia), Löwenstein Medical (Germany), Drive DeVilbissHealthcare (US), BMC Medical (China), Braebon Medical (Canada), and PantheraDental (Canada) among others.
Sleep Apnea Devices MarketSegmentation
By Type
1. Diagnostic Devices
· PolysomnographyDevices
· RespiratoryPolygraphs
· ActigraphySystems
· Single-ChannelScreening Devices
2. Therapeutic Devices
· FacialInterfaces
· AdaptiveServo-Ventilation Instruments (ASV)
· PositiveAirway Pressure (PAP) Devices
· OxygenConcentrators
· AirwayClearance Systems
· OralAppliances and Accessories
By End User
· HomeHealthcare
· SleepLaboratories & Hospitals
By Region
· North America(US and Canada)
· Europe (UK,Germany, France and Rest of Europe)
· Asia Pacific(China, Japan, India and Rest of Asia Pacific)
· Latin America(Brazil, Mexico and Rest of Latin America)
· Middle East& Africa (GCC and Rest of Middle East & Africa)
Key Findings:
- Based on the type, the diagnostic devices segment is estimated to lead the market in 2018
- Based on diagnostic devices sub-type, the polysomnography devices segment is expected to grow at the highest CAGR of around 14% during the forecast period
- Based on the therapeutic devices sub-type, the oral appliances and accessories segment is anticipated to grow at the fastest rate of 13% during the forecast period
- Based on end user, the sleep laboratories & hospitals segment came out as a leading sector for the global sleep apnea devices market by accounting more than 78% of the total market, in 2018
- Based on region, North America region which is fuelled by growth in banking and online retail segment, accounted largest market share globally by contributing more than 37% share in 2018
Read More- https://www.alltheresearch.com/report/229/sleep-apnea-devices-market
Recent News:
- In July 2019, US based sleep apnea devices solution provider ResMed announced launch of AirFit N30i, which is its first top-of-head-connected nasal CPAP mask
- In May 2016, Koninklijke Philips (Netherlands) introduced its sleep apnea device solutions in form of DreamWear mask, DreamStation PAP device, and DreamMapper patient engagement app
